Target Pipelines
In this product category, you will find reports in a tabular format providing you with the most uptodate competitive intelligence information about target-specific R&D pipelines. This low-cost product service provides information about active R&D projects for a given target in the format of Word tables.
Subscribe to
our newsletters!
Showing 1–20 of 31 resultsSorted by latest
-
July of 2025This competitive intelligence report about TL1A Inhibitors and DR3 Antagonists provides a competitor evaluation in the field of mostly antibodies targeting TNF-like ligand 1A (TL1A) or death receptor 3 (DR3) as...€ 200.00
-
July of 2025This competitive intelligence report about TSLP Inhibitors and TSLP Receptor Antagonists provides a competitor evaluation in the field of mostly antibodies targeting Thymic Stromal Lymphopoietin (TSLP) or its receptor as of...€ 300.00
-
March of 2025This Competitive Intelligence report about PSMA-Targeted Therapy & Radiodiagnostics provides a competitor evaluation in the field of imaging of PSMA-positive prostate cancer and of PSMA-targeted therapy as of March of 2025€ 500.00
-
August of 2024This product provides basic pipeline information on investigational immunotherapeutics targeting CD47 or SIRP-alpha.€ 400.00
-
On the same day of purchaseThis product provides basic pipeline information on investigational antibodies targeting B7-H4.€ 200.00
-
July of 2024This product provides basic pipeline information on investigational bispecific antibodies targeting PD-L1 and 4-1BB.€ 200.00
-
This product provides basic pipeline information on investigational antibodies, antisense and small molecules inhibiting CD38.€ 200.00
-
April of 2024Competitor evaluation of recombinant antibodies and cellular therapeutics targeting claudin 18.2 as of April 2024€ 430.00
-
March of 2024This product provides basic information on approved and investigational antibodies, cell therapies and small molecules targeting CD38.€ 300.00
-
March of 2024This product provides basic information on immunotherapy candidates in research and development targeting 5T4.€ 100.00
-
On the same day of purchaseThis product provides basic information on immunotherapeutics in R&D targeting Her3.€ 300.00
-
On the same day of purchaseThis product provides basic information on immunotherapeutics on the market and in R&D targeting TROP-2.€ 300.00
-
On the same day of purchaseThis product provides basic information on immunotherapeutics on the market and in R&D targeting nectin-4€ 200.00
-
On the same day of purchaseThis product provides basic information on approved products and R&D candidates targeting FcRn.€ 200.00
-
On the same day of purchaseThis product provides basic information on immunotherapy candidates in research and development targeting DLL3.€ 200.00
-
On the same day of purchaseThis product provides basic information on immunotherapy candidates in research and development targeting B7-H3.€ 300.00
-
On the same day of purchaseThis product provides basic information on antibody therapy candidates in R&D targeting EpCAM.€ 200.00
-
On the same day of purchaseThis product provides basic information on antibody therapy candidates in R&D targeting PD-1.€ 200.00
-
On the same day of purchaseThis product provides basic information on antibody therapy candidates in R&D targeting c-Met.€ 300.00
-
On the same day of purchaseThis product provides basic information on immunotherapy candidates in research and development targeting mesothelin€ 300.00